Clinical trials: Adrenal Gland Neoplasms
Adrenocortical Carcinoma
Single Agent Pembrolizumab in Subjects With Advanced Adrenocortical Carcinoma
Pembrolizumab is a type of immunotherapy, and the purpose of this study is to find out what effects, good and/or bad, pembrolizumab has on you, and your cancer.
- Trial name
- NCT02673333
- Testing
- Pembrolizumab
- Where
- 2 sites in United States
- Volunteers
- 39 people
- Sponsor
- Memorial Sloan Kettering Cancer Center
Adrenal Tumors
Changes in Adrenal Hormones During Adrenal Radiofrequency Ablation
The purpose of this study is to evaluate changes in adrenal hormones during adrenal radiofrequency (RF) ablation.
- Trial name
- NCT00997594
- Testing
- Radiofrequency ablation
- Where
- 2 sites in Japan
- Volunteers
- 18 people
- Sponsor
- Mie University
Adrenocortical Carcinoma, Peritoneal Carcinomatosis
Surgery and Heated Chemotherapy for Adrenocortical Carcinoma
Background: Adrenocortical carcinoma (ACC) is a rare tumor of the adrenal gland. Few people who develop this disease live more than 5 years after being diagnosed.
- Trial name
- NCT01833832
- Testing
- Cisplatin, Cytoreductive surgery, sodium thiosulfate
- Where
- United States
- Volunteers
- 11 people
- Sponsor
- National Cancer Institute (NCI)